Latest News
-
FREE, FREE, FREE! 3:1 Bonus: Pharma Stock Hits Back-To-Back Upper Circuits; 500 Shares To Earn Rs 1,69,500 -
1:10 Stock Split: Below Rs 10, Fertilizer Sector Turned Ex-Split; 8,282% Returns In 5 Years -
Rs 17/Share Dividend: Record Date On April 26; Buy The ICICI Group Stock To Be Eligible? -
Honasa Consumer to Strengthen Operations by Merging Fusion Cosmeceutics and Just4Kids -
Wipro Reports 7.8% Decline in Q4 Net Profit; CEO Highlights Economic Challenges -
IREDA Hits Record Annual PAT of Rs 1,252 Cr in FY24; Q4 Profits Up by 33% -
Massive Employee Exodus Hits India's Top IT Companies in FY23-24 -
Air India Enhances Operational Efficiency with New Crew Management System -
BlackRock Acquires Shares in Electrosteel Castings and PTC India for Rs 207 Crore -
IndiGo Enhances Domestic Routes with Direct Chennai-Durgapur Flights
Laxmi Organics Files DRHP With SEBI for Rs. 800 Crore IPO
As companies across sectors want to tap the current stock market momentum, another Mumbai-based specialty chemicals company, Laxmi Organics has filed the draft red herring prospectus (DRHP) with the SEBI on Wednesday for floating its public issue or IPO.
The company's public issue comprises of a fresh issue of Rs. 500 crore and an OFS by promoter Yellow Stone Trust of Rs. 300 crore.
The company in the year 1992 began its operations as a manufacturer of acetaldehyde and acetic acid and later has emerged as the largest ethyl acetate manufacturing company in India.
Laxmi Orgnaics will use the proceeds to set up a manufacturing unit for fluorospecialty chemicals, working capital requirements, purchase of plant and machinery, repayment of certain outstanding, upgrading existing units, and general corporate purposes, it said.
Axis Capital and DAM Capital Advisors have been appointed as the managers to the issue.
GoodReturns.in
